Universität zu Köln

Hombach, A., Hombach, A. A. and Abken, H. (2010). Adoptive immunotherapy with genetically engineered T cells: modification of the IgG1 Fc 'spacer' domain in the extracellular moiety of chimeric antigen receptors avoids 'off-target' activation and unintended initiation of an innate immune response. Gene Ther., 17 (10). S. 1206 - 1214. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5462

Full text not available from this repository.

Abstract

Chimeric antigen receptors (CARs, immunoreceptors) are frequently used to redirect T cells with pre-defined specificity, in particular towards tumour cells for use in adoptive immunotherapy of malignant diseases. Specific targeting is mediated by an extracellularly located antibody-derived binding domain, which is joined to the transmembrane and intracellular CD3 zeta moiety for T-cell activation. Stable CAR expression in T cells, however, requires a spacer domain interposed between the binding and the transmembrane domain and which is commonly the constant IgG1 Fc domain. We here revealed that CARs with Fc spacer domain bind to IgG Fc gamma receptors (Fc gamma Rs), thereby unintentionally activating innate immune cells, including monocytes and natural killer (NK) cells, which consequently secrete high amounts of pro-inflammatory cytokines. Engineered T cells, on the other hand, are likewise activated by Fc gamma R binding resulting in cytokine secretion and lysis of monocytes and NK cells independently of the redirected specificity. To reduce Fc gamma R binding, we modified the spacer domain without affecting CAR expression and antigen binding. Engineered with the modified CAR, T cells are not activated in presence of Fc gamma R+ cells, thereby minimizing the risk of off-target activation while preserving their redirected targeting specificity. Gene Therapy (2010) 17, 1206-1213; doi:10.1038/gt.2010.91; published online 17 June 2010

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Hombach, A. UNSPECIFIED UNSPECIFIED UNSPECIFIED Hombach, A. A. UNSPECIFIED UNSPECIFIED UNSPECIFIED Abken, H. UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-495598
DOI:	10.1038/gt.2010.91
Journal or Publication Title:	Gene Ther.
Volume:	17
Number:	10
Page Range:	S. 1206 - 1214
Date:	2010
Publisher:	NATURE PUBLISHING GROUP
Place of Publication:	LONDON
ISSN:	1476-5462
Language:	English
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language SINGLE-CHAIN; HODGKINS LYMPHOMA; TUMOR-CELLS; BINDING; LYMPHOCYTES; CANCER; NEUROBLASTOMA; SPECIFICITY; THERAPY; PATIENT Multiple languages Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental Multiple languages
URI:	http://kups.ub.uni-koeln.de/id/eprint/49559